These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 16365197)

  • 1. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.
    Briand F; Tréguier M; André A; Grillot D; Issandou M; Ouguerram K; Sulpice T
    J Lipid Res; 2010 Apr; 51(4):763-70. PubMed ID: 19965597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.
    Yasuda T; Grillot D; Billheimer JT; Briand F; Delerive P; Huet S; Rader DJ
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):781-6. PubMed ID: 20110577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.
    Calpe-Berdiel L; Rotllan N; Fiévet C; Roig R; Blanco-Vaca F; Escolà-Gil JC
    J Lipid Res; 2008 Sep; 49(9):1904-11. PubMed ID: 18509196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR.
    Khovidhunkit W; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
    J Lipid Res; 2003 Sep; 44(9):1728-36. PubMed ID: 12777468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice.
    Kruit JK; Plösch T; Havinga R; Boverhof R; Groot PH; Groen AK; Kuipers F
    Gastroenterology; 2005 Jan; 128(1):147-56. PubMed ID: 15633131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
    Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
    Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
    Zanotti I; Potì F; Pedrelli M; Favari E; Moleri E; Franceschini G; Calabresi L; Bernini F
    J Lipid Res; 2008 May; 49(5):954-60. PubMed ID: 18252848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
    Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo.
    Zhang Y; Zanotti I; Reilly MP; Glick JM; Rothblat GH; Rader DJ
    Circulation; 2003 Aug; 108(6):661-3. PubMed ID: 12900335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.
    Brunham LR; Kruit JK; Pape TD; Parks JS; Kuipers F; Hayden MR
    Circ Res; 2006 Sep; 99(7):672-4. PubMed ID: 16946132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
    Breevoort SR; Angdisen J; Schulman IG
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport.
    Tanigawa H; Billheimer JT; Tohyama J; Zhang Y; Rothblat G; Rader DJ
    Circulation; 2007 Sep; 116(11):1267-73. PubMed ID: 17709636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice.
    Nijstad N; Gautier T; Briand F; Rader DJ; Tietge UJ
    Gastroenterology; 2011 Mar; 140(3):1043-51. PubMed ID: 21134376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke.
    Morales JR; Ballesteros I; Deniz JM; Hurtado O; Vivancos J; Nombela F; Lizasoain I; Castrillo A; Moro MA
    Circulation; 2008 Sep; 118(14):1450-9. PubMed ID: 18794391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
    Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
    Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.